Cephalosporin antibiotics represent a cornerstone in the fight against bacterial infections, offering a broad spectrum of activity and a generally favorable safety profile. The synthesis of these critical medications involves complex multi-step processes, where specific chemical intermediates play indispensable roles. DL-2-(2-Chlorophenyl)glycine, identified by CAS 141196-64-7, is one such pivotal intermediate. NINGBO INNO PHARMCHEM CO.,LTD., a leading pharmaceutical intermediate supplier in China, is a key provider of this essential compound.

The molecular structure of DL-2-(2-Chlorophenyl)glycine makes it a highly versatile building block for organic synthesis. In the context of cephalosporin production, it contributes essential structural elements required for the formation of the characteristic beta-lactam ring system and the side chains that dictate the antibiotic's spectrum of activity and pharmacokinetic properties. The high purity (≥99.0%) of our DL-2-(2-Chlorophenyl)glycine ensures that it contributes effectively and without introducing unwanted impurities into the synthesis pathway.

Reliability in the supply chain is paramount for pharmaceutical manufacturers. Producing antibiotics at scale requires a consistent and dependable source of high-quality intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being that reliable partner, offering DL-2-(2-Chlorophenyl)glycine that meets stringent quality specifications and is manufactured under GMP conditions. This focus on quality and consistency is crucial for maintaining the integrity and efficacy of the final cephalosporin products.

For pharmaceutical companies engaged in the production of cephalosporin antibiotics, sourcing DL-2-(2-Chlorophenyl)glycine from a trusted manufacturer in China like NINGBO INNO PHARMCHEM CO.,LTD. provides a strategic advantage. Our advanced manufacturing capabilities and unwavering commitment to quality assurance ensure that you receive a product that meets the demanding requirements of antibiotic synthesis. We support your efforts to bring essential medicines to market.